current
pandem
coronaviru
recent
identifi
patient
acut
respiratori
syndrom
compar
pathogenesi
previous
emerg
coronavirus
inocul
cynomolgu
macaqu
merscov
compar
patholog
virolog
histor
report
sarscov
infect
macaqu
viru
excret
nose
throat
absenc
clinic
sign
detect
type
ii
pneumocyt
foci
diffus
alveolar
damag
ciliat
epitheli
cell
nasal
bronchial
bronchiolar
mucosa
sarscovinfect
lung
lesion
typic
sever
milder
merscov
infect
viru
detect
mainli
type
ii
pneumocyt
data
show
caus
diseas
macaqu
provid
new
model
test
prevent
therapeut
strategi
swab
age
anim
compar
young
anim
rna
detect
throat
swab
peak
day
pi
young
day
pi
age
anim
decreas
rapidli
time
comparison
nasal
swab
could
still
detect
intermitt
day
pi
fig
low
level
infecti
viru
cultur
throat
nasal
swab
day
respect
tabl
support
viru
shed
anim
environment
sampl
perform
determin
potenti
contamin
surfac
environment
sampl
indic
presenc
low
level
rna
surfac
direct
contact
hand
indirect
contamin
within
isol
tabl
rna
detect
rectal
swab
one
anim
day
pi
viral
rna
detect
whole
blood
time
point
throughout
studi
autopsi
four
macaqu
day
pi
two
foci
pulmonari
consolid
lung
fig
one
anim
age
year
show
consolid
right
middl
lobe
repres
less
lung
tissu
second
anim
young
year
two
foci
left
lower
lobe
repres
lung
tissu
fig
consolid
lung
tissu
wellcircumscrib
redpurpl
level
less
buoyant
normal
organ
two
macaqu
well
respiratori
tract
organ
two
anim
normal
viru
replic
assess
rtqpcr
day
pi
tissu
respiratori
digest
urinari
cardiovascular
tract
endocrin
central
nervou
system
well
variou
lymphoid
tissu
viru
replic
primarili
restrict
respiratori
tract
nasal
caviti
trachea
bronchi
lung
lobe
highest
level
rna
lung
fig
interestingli
three
four
anim
rna
also
detect
ileum
tracheobronchi
lymph
node
fig
main
histolog
lesion
consolid
pulmonari
tissu
young
age
anim
involv
alveoli
bronchiol
consist
area
acut
advanc
dad
fig
area
lumina
alveoli
bronchiol
variabl
fill
proteinrich
edema
fluid
fibrin
cellular
debri
alveolar
macrophag
fewer
neutrophil
lymphocyt
fig
epitheli
necrosi
extens
loss
epithelium
alveolar
bronchiolar
wall
hyalin
membran
present
damag
alveoli
area
advanc
lesion
alveolar
wall
moder
thicken
line
cuboid
epitheli
cell
type
ii
pneumocyt
hyperplasia
alveolar
lumina
empti
alveolar
bronchiolar
wall
thicken
edema
fluid
mononuclear
cell
neutrophil
aggreg
lymphocyt
around
small
pulmonari
vessel
moder
number
lymphocyt
macrophag
present
lamina
propria
submucosa
bronchial
wall
neutrophil
bronchial
epithelium
regener
epithelium
seen
bronchiol
visibl
irregular
layer
squamou
high
cuboid
epitheli
cell
hyperchromat
nuclei
occasion
multinucl
giant
cell
syncytia
free
lumina
bronchiol
alveoli
fig
base
posit
pankeratin
stain
neg
stain
appear
origin
epitheli
cell
fig
inset
antigen
express
detect
moder
number
type
pneumocyt
type
ii
pneumocyt
within
foci
dad
fig
fig
fig
pattern
stain
similar
lung
tissu
sarscovinfect
macaqu
posit
control
antigen
express
observ
syncytia
addit
antigen
express
detect
nonlesion
tissu
lung
lobe
three
four
macaqu
young
one
age
type
ii
pneumocyt
bronchial
ciliat
epitheli
cell
bronchiolar
ciliat
epitheli
cell
age
macaqu
without
virolog
patholog
evid
infect
lung
antigen
express
ciliat
epitheli
cell
nasal
septum
fig
nasal
concha
palatum
moll
absenc
associ
histopatholog
chang
sarscovantigen
express
detect
sampl
tissu
includ
brain
intestin
assess
sever
infect
compar
merscov
young
cynomolgu
macaqu
year
age
inocul
merscov
via
rout
anim
remain
free
clinic
sign
day
pi
remain
anim
seroconvert
reveal
presenc
merscov
specif
antibodi
sera
elisa
fig
merscov
rna
detect
nasal
fig
throat
swab
fig
day
pi
peak
day
pi
respect
low
level
equivalentml
merscov
rna
detect
rectal
swab
day
pi
autopsi
four
macaqu
day
pi
three
anim
foci
pulmonari
consolid
character
slightli
depress
area
lung
repres
less
lung
tissu
tabl
similar
infect
young
age
anim
day
pi
merscov
rna
primarili
detect
respiratori
tract
inocul
anim
fig
infecti
viru
titer
compar
lower
compar
sarscov
infect
young
macaqu
tabl
addit
merscov
rna
detect
spleen
tabl
consist
presenc
viru
lower
respiratori
tract
day
pi
histopatholog
chang
characterist
dad
observ
lung
inocul
anim
fig
alveolar
septa
thicken
owe
infiltr
neutrophil
macrophag
moder
type
ii
pneumocyt
hyperplasia
hypertrophi
alveolar
lumina
elev
alveolar
macrophag
edema
fluid
contain
fibrin
neutrophil
fig
syncyti
cell
seen
alveolar
lumina
interestingli
merscov
antigen
detect
tissu
day
pi
part
respiratori
tract
therefor
sampl
four
young
macaqu
day
pi
time
observ
multifoc
express
viral
antigen
predominantli
type
ii
pneumocyt
occasion
type
pneumocyt
bronchiolar
bronchial
epitheli
cell
macrophag
fig
summari
inocul
young
age
cynomolgu
macaqu
low
passag
clinic
isol
result
product
infect
absenc
overt
clinic
sign
recent
studi
human
case
shown
presymptomat
asymptomat
case
also
shed
viru
increas
age
affect
diseas
outcom
prolong
viral
shed
upper
respiratori
tract
age
anim
prolong
shed
observ
sarscov
patient
interestingli
shed
asymptomat
model
peak
earli
cours
infect
similar
seen
symptomat
patient
also
antigen
detect
ciliat
epitheli
cell
nasal
mucosa
day
pi
seen
sarscov
merscov
infect
manuscript
anim
model
viral
tropism
nasal
mucosa
fit
effici
respiratori
transmiss
seen
influenza
viru
earli
peak
viru
shed
similar
influenza
viru
shed
may
explain
case
detect
isol
may
effect
control
sarscov
primarili
detect
tissu
respiratori
tract
howev
rna
also
detect
tissu
intestin
line
recent
report
similar
result
regard
viral
shed
tissu
cell
tropism
recent
also
report
follow
inocul
rhesu
macaqu
howev
unlik
model
infect
rhesu
macaqu
result
transient
respiratori
diseas
weight
loss
two
four
anim
foci
dad
day
pi
colocalis
express
dad
provid
strong
evid
infect
caus
lesion
histolog
charact
dad
includ
alveolar
bronchiolar
epitheli
necrosi
alveolar
edema
hyalin
membran
format
accumul
neutrophil
macrophag
lymphocyt
correspond
limit
patholog
analys
human
case
particular
presenc
syncytia
lung
lesion
characterist
respiratori
coronaviru
infect
wherea
merscov
primarili
infect
type
ii
pneumocyt
cynomolgu
macaqu
sarscov
also
infect
type
pneumocyt
injuri
type
pneumocyt
result
pulmonari
edema
format
hyalin
membran
may
explain
hyalin
membran
format
hallmark
sar
frequent
report
mer
data
show
cynomolgu
macaqu
permiss
infect
shed
viru
prolong
period
time
display
diseas
nonhuman
primat
model
replic
effici
respiratori
epitheli
cell
throughout
respiratori
tract
includ
nasal
caviti
bronchi
bronchiol
alveoli
replic
upper
respiratori
tract
fit
effici
transmiss
host
replic
lower
respiratori
tract
fit
develop
lung
diseas
indepth
comparison
infect
sarscov
merscov
model
may
identifi
key
pathway
pathogenesi
emerg
virus
studi
provid
novel
infect
model
critic
evalu
licensur
prevent
therapeut
strategi
infect
use
human
well
evalu
efficaci
repurpos
speci
specif
exist
treatment
pegyl
interferon
